 |
| |
| EU supports EMEA to extend indications for Acomplia |
| Riding on the roller coaster, Acomplia is making good advances as the European Commission endorsed the positive opinion of the European Medicines Evaluation Agency (EMEA) for Acomplia (rimonabant) to include type 2 diabetes trial results in the European Label. |
| Read More... |
| GlaxoSmithKline Hands WCRS £30m Weight Loss Pill Account |
| GlaxoSmithKline’s weight loss pill Alli is selling like a hot cake. In their next stride, GlaxoSmithKline has appointed WCRS to handle the £30m advertising for the pan-European launch of its weight loss ‘wonder-drug' Alli. |
| Read More... |
| Sanofi-Aventis prompt response to Lancet Report on Acomplia |
| Concerned by the Lancet report and a similar report that appeared this week in the British Medical Journal, Acomplia’s manufacturer Sanofi-aventis leaped out a statement on Nov.16th responding to the stories. |
| Read More... |
| Glaxo Sells 2 Million Starter Kits of Diet Pill Alli |
| Since Alli hit shelves in June, two million starter
kits of this first over-the-counter weight loss pill were sold
in the five months, GlaxoSmithKline said. |
| Read More... |
| Get A New Slim Look With Acomplia |
| Acomplia — manufactured by Sanofi-Aventis
— is proving effective and safe in weight loss treatment.
In a recent study, it reported that 39% of patients, after the
first year of treatment, taking high-dose Acomplia were able
to reach a goal of losing 10% of their weight. |
| Read More... |
| Prohibited Diet Pill Loaded With Drug Resurfaces |
| Amphetamine-fortified Brazilian diet pills which
were banished by U.S. regulators a year ago likely to have resurfaced
in South Florida under a new name. |
| Read More... |
| Alli
is going strong in the market |
| Alli -- manufactured
by GlaxoSmithKline -- is a less potent form
of the prescription drug orlistat. The drug
orlistat was marketed under the trade name Xenical
by Roche Holding, which had limited success on the market. |
| Read
More... |
| Copies
of Diet Drug Acomplia (Rimonabant) gaining popularity in India |
| Sanofi-Aventis' Diet drug Acomplia
(rimonabant) is getting quite good responses at Indian pharmacies.
According to reports from the Indian media, Acomplia in generic
form is being sold without a prescription for as little as 12
cents. |
| Read
More... |
| Diet Pill Rimonabant is all set to make impact |
| Growing number of overweight individuals are
not happy with the performance of over-the-counter diet pills
alli. As a result, alli is not getting
substantial positive response and it's disappearing |
| Read
More... |
| Diet
drug Alli officially sanctioned to be sold over-the-counter |
| The exciting news for million of over weight
Americans and Europeans is that now the drug Alli-
big breakthrough in obesity treatment. |
| Read
More... |
| Alli
is on a new high. |
| It's good news for GlaxoSmithKline's diet
pill alli as its rival competitors Sanofi's Accomplia
will not be sold in the market for the time being. |
| Read
More... |
| |
